MedPath

The study on the efficacy of intraperitoneal administration of triamcinolone acetonide to cancerous ascites in end-of-life patients

Not Applicable
Recruiting
Conditions
cancer
Registration Number
JPRN-UMIN000034123
Lead Sponsor
Ashiya Municipal Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

Patients that do not satisfy the above selection criteria.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The duration of ascites removal
Secondary Outcome Measures
NameTimeMethod
Variations of symptoms before and after removal of ascites
© Copyright 2025. All Rights Reserved by MedPath